XPRIZE Announces Teams Advancing in $15M Global Learning XPRIZE at EdTechXEurope
21.6.2017 13:00 | Business Wire
Today, XPRIZE, the world’s leader in designing and managing incentive competitions to solve humanity’s grand challenges, announced 11 semi-finalists advancing in the $15M Global Learning XPRIZE. Announced at this year’s EdTechXEurope, XPRIZE is challenging these semi-finalist teams to develop open source and scalable software that will enable children in developing countries to teach themselves basic reading, writing and arithmetic within 15 months.
“Throughout my career, I’ve seen the many ways technology has evolved to help children access an education they may otherwise not have,” said Matt Keller, senior director of the Global Learning XPRIZE. “What most excites XPRIZE about these semi-finalist teams is the possibility that their innovative software solutions can exponentially transform the way learning happens across the world, especially in places where children simply cannot get to school.”
The semi-finalists were chosen by an independent judging panel of 11 experts from a field of 198 teams following XPRIZE’s initial launch in September 2014. Semi-finalists will have one month to update and finalize their solutions before the judges select five finalist teams to proceed to the final round of the competition.
The 11 teams advancing are:
- AutoCognita (Hong Kong, China & Bellingham, United States) is focused on helping students acquire core literacy and numeracy skills through a structured curriculum, active learning pedagogy and user experience-focused design.
- CCI (New York, United States) is developing structured and sequential instructional programs, in addition to a platform seeking to enable non-coders to develop engaging learning content in any language or subject area.
- Chimple (Bangalore, India) is developing a learning platform aimed at enabling children to learn reading, writing and mathematics on a tablet through more than 60 explorative games and 70 different stories.
- Education Apps for All (Lynchburg, United States) is developing an app that aims to systematically teach the building blocks of reading while encouraging oral language development and reading comprehension.
- Leap to Know (Pretoria, South Africa) is developing an app rich with culturally relevant stories that help to build learning foundations for children at different education levels.
- Learn Leap Fly (Ottawa, Canada) is using social software and story-based learning to deliver a culture and language-adaptable learning platform for reading, writing, and arithmetic.
- LiteracyApp.org (Kristiansand, Norway) is using exponential technologies like face recognition and machine learning to build an artificial intelligence (AI) tutor able to adapt itself to different children.
- onebillion (UK/Malawi/Tanzania) is merging numeracy content with new literacy material to offer directed learning and creative activities alongside continuous monitoring to respond to different children’s needs.
- RoboTutor (Pittsburgh, United States) is leveraging Carnegie Mellon's research in reading and math tutors, speech recognition and synthesis, machine learning, educational data mining, cognitive psychology, and human-computer interaction.
- Kitkit School (Berkeley, United States) is developing a learning program with a game-based core and flexible learning architecture aimed at helping children independently learn, irrespective of their knowledge, skill, and environment.
- The School of Games (San Francisco, United States) is creating a series of games to teach reading, writing, numeracy and speaking skills that adapt to different learning styles.
To be announced this September, the five finalist teams will each receive a $1 million milestone award. With the competition’s global partnerships including the United Nations’ Educational, Scientific and Cultural Organization (UNESCO), the World Food Programme (WFP), and the government of Tanzania, the teams’ solutions will be field-tested with 4,000 children in 150 villages in the Tanga region of Tanzania for approximately 15 months on 8,000 Pixel C tablets donated by Google. At the end of the field-testing phase, the team whose solution enables the greatest proficiency gains in reading, writing and arithmetic will receive the Grand Prize of $10 million, to be announced in April 2019. In addition, each of the five finalists will be required to open source both their code and their content which will be free and available for anyone to build on.
An estimated 250 million children around the world cannot read, write or demonstrate basic arithmetic skills. UNESCO estimates that the world needs 1.6 million more teachers globally, a number set to double by 2030. The Global Learning XPRIZE will help prove that with the right education technology resources and partnerships, children can teach themselves to read, write and do arithmetic. By ensuring each finalists’ solutions are open source, XPRIZE also aims to proliferate solutions worldwide at the intersection of technology and learning.
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. XPRIZE utilizes a unique combination of gamification, crowd-sourcing, incentive prize theory, and exponential technologies as a formula to make 10x (vs. 10%) impact in the grand challenge domains facing our world. XPRIZE’s philosophy is that—under the right circumstances—igniting rapid experimentation from a variety of diverse lenses is the most efficient and effective method to driving exponential impact and solutions to grand challenges. Active competitions include the $30M Google Lunar XPRIZE, the $20M NRG COSIA Carbon XPRIZE, the $15M Global Learning XPRIZE, the $7M Shell Ocean Discovery XPRIZE, the $7M Barbara Bush Foundation Adult Literacy XPRIZE, the $5M IBM Watson AI XPRIZE, the $1.75M Water Abundance XPRIZE and the $1M Anu and Naveen Jain Women’s Safety XPRIZE. For more information, visit www.xprize.org.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 16:25 | Tiedote
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 15:00 | Tiedote
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 11:03 | Tiedote
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 11:00 | Tiedote
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 10:08 | Tiedote
Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 09:00 | Tiedote
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme